Clinical Trial Update: Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults [Phase 3]

View source ↗

Summary

Lyra Therapeutics reported efficacy and safety results from a Phase 3 trial of LYR-210 in adults with chronic rhinosinusitis; the study has completed and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis

Drugs mentioned

• LYR-210

Snippet

Sponsor: Lyra Therapeutics | Conditions: Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis) | Phase 3 | Status: COMPLETED | Results posted: 2025-05-02